The global Diosmin API market size was valued at approximately USD 500 million in 2023 and is expected to reach around USD 850 million by 2032, growing at a CAGR of 6.5% during the forecast period. Several factors are driving this growth, including the increasing prevalence of chronic venous diseases and rising awareness about the benefits of flavonoid-based treatments.